Detalhe da pesquisa
1.
Hidden in plain sight - Survival consequences of baseline symptom burden in women with recurrent ovarian cancer.
Gynecol Oncol
; 185: 128-137, 2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38412736
2.
Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study.
Int J Gynecol Cancer
; 32(6): 761-768, 2022 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35086926
3.
Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) - Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS).
Gynecol Oncol
; 148(1): 36-41, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29107348
4.
Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer.
Qual Life Res
; 27(1): 59-74, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29248998
5.
The impact of body composition parameters on ipilimumab toxicity and survival in patients with metastatic melanoma.
Br J Cancer
; 116(3): 310-317, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28072766
6.
Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study.
Oncologist
; 22(9): 1117-1124, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28596446
7.
Thrombolysis and iliofemoral vein stent placement in cancer patients with lower extremity swelling attributed to lymphedema.
J Vasc Interv Radiol
; 26(1): 39-45, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25541444
8.
Effect of chemotherapy on quality of life in patients with non-small cell lung cancer.
Support Care Cancer
; 22(5): 1417-28, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24563068
9.
Apalutamide-Induced Toxic Epidermal Necrolysis in a Caucasian Patient with Metastatic Castration-Sensitive Prostate Cancer: A Case Report and Review of the Literature.
Case Rep Oncol
; 16(1): 652-661, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37900799
10.
A pilot study investigating feasibility of mainstreaming germline BRCA1 and BRCA2 testing in high-risk patients with breast and/or ovarian cancer in three tertiary Cancer Centres in Ireland.
Fam Cancer
; 22(2): 135-149, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36029389
11.
A cost comparison study to review community versus acute hospital models of nursing care delivered to oncology patients.
Eur J Oncol Nurs
; 49: 101842, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33126156
12.
Rapid and sustained airway control in metastatic malignant melanoma: a case report.
ERJ Open Res
; 5(4)2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31803770
13.
Complex symptom control with early integrated palliative medicine for a primary mediastinal mass.
BMJ Support Palliat Care
; 13(e3): e977-e980, 2024 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37402539
14.
Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08-10 trial.
Ther Adv Med Oncol
; 11: 1758835919864236, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31384312
15.
An assessment of histological margins and recurrence of melanoma in situ.
Plast Reconstr Surg Glob Open
; 3(2): e301, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25750840
16.
High-throughput oncogene mutation profiling shows demographic differences in BRAF mutation rates among melanoma patients.
Melanoma Res
; 25(3): 189-99, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25746038
17.
Impact of adverse events, treatment modifications, and dose intensity on survival among patients with advanced renal cell carcinoma treated with first-line sunitinib: a medical chart review across ten centers in five European countries.
Cancer Med
; 3(6): 1517-26, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25045157
18.
Angiogenesis inhibitor therapies for advanced renal cell carcinoma: toxicity and treatment patterns in clinical practice from a global medical chart review.
Int J Oncol
; 44(1): 5-16, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24247547
19.
Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial.
J Clin Oncol
; 31(26): 3197-204, 2013 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23940225
20.
Phase II clinical trial of first or second-line treatment with bortezomib in patients with malignant pleural mesothelioma.
J Thorac Oncol
; 7(9): 1466-70, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22895144